XLV290119C00166000
XLV Jan 19 2029 166.00 Call
optionOPRA
InactiveOct 6, 2026
25.20USD+0.800%(+0.20)1Vol4OI
Loading…
Underlying
Underlying Price
$184.80
Type
Call
Strike
166
Expiration
Jan 19, 2029
DTE
804d
Moneyness
ITM
Intrinsic
$18.80
XLV 166 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Nov 6, 2026 | -1d | $25.04 | +5.34% | 1 | 37 |
| Nov 13, 2026 | 6d | $15.55 | +228.06% | 14 | 13 |
| Nov 20, 2026 | 13d | $16.03 | +12.41% | 1 | 8 |
| Nov 27, 2026 | 20d | — | — | 0 | 0 |
| Dec 4, 2026 | 27d | $15.51 | +0.00% | 1 | 1 |
| Dec 11, 2026 | 34d | — | — | 0 | 0 |
| Jan 15, 2027 | 69d | $24.25 | +20.65% | 4 | 272 |
| Mar 19, 2027 | 132d | $17.10 | +34.96% | 1 | 27 |
| Jun 17, 2027 | 222d | $11.78 | +0.68% | 1 | 40 |
| Jan 19, 2029 | 804d | $25.20 | +0.80% | 1 | 4 |
XLV Nearby Strikes · Jan 19, 2029
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 160 C | $43.01 | -0.19% | 12 | 24 | ITM |
| 161 C | — | — | 0 | 0 | ITM |
| 162 C | $26.92 | -8.59% | 3 | 2 | ITM |
| 163 C | — | — | 0 | 0 | ITM |
| 164 C | $29.88 | +21.71% | 1 | 5 | ITM |
| 165 C | $41.45 | +4.30% | 2 | 28 | ITM |
| 166 C | $25.20 | +0.80% | 1 | 4 | ITM |
| 167 C | — | — | 0 | 0 | ITM |
| 168 C | $24.16 | +0.00% | 1 | 1 | ITM |
| 169 C | $32.57 | +25.66% | 1 | 10 | ITM |
| 170 C | $37.00 | +3.67% | 1 | 25 | ITM |
| 171 C | $29.30 | +23.11% | 1 | 3 | ITM |
| 172 C | $30.33 | +41.80% | 2 | 6 | ITM |
XLV Profile
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.